Louai Alsaloumi

Dr. Louai Alsaloumi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2019 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
LALouai Alsaloumi
Louai Alsaloumi
AAAbdikarim Abdi
Abdikarim Abdi
ÖTÖzgür Tosun
Özgür Tosun
BBBilgen Başgut
Bilgen Başgut

18 September 2020 in Oncology Research and Treatment
Verified
Journal Article
Closed access
PDF file
LALouai Alsaloumi
Louai Alsaloumi
SSShaima Shawagfeh
Shaima Shawagfeh
AAAbdikarim Abdi
Abdikarim Abdi
BBBilgen Basgut
Bilgen Basgut
Background: Capecitabine is frequently used alone or combined with other chemotherapy agents for the treatment of metastatic breast cancer in relapsed patients. Objective: The objective of this meta-analysis is to evaluate the effectiveness and safety of capecitabine monotherapy versus combination in the treatment of metastatic breast cancer patients pretreated with anthracycline and taxane. Methods: Eligible randomized controlled trials examining the efficacy and safety of capecitabine alone compared to capecitabine combination were systematically searched. Progression-free survival (PFS), overall survival (OS), overall response rate (ORR), and grades 3–4 drug-related adverse events were the outcomes assessed. Results: A total of 6,714 patients of 9 trials were involved in the pooled analysis. Our findings demonstrated that capecitabine combination is significantly superior to capecitabine monotherapy in improving PFS (hazard ratio [HR] 1.32, 95% CI 1.13–1.54, p < 0.0001) and ORR (risk ratio [RR] 0.67, 95% CI 0.54–0.83, p < 0.001), but it was insignificant in OS (HR 1.09, 95% CI 0.98–1.22, p = 0.12). On the other hand, the incidence of non-hematological adverse events such as hand-foot syndrome and diarrhea was lower in capecitabine combination compared to capecitabine monotherapy. Conclusion: Capecitabine-based combination chemotherapy showed superiority over capecitabine monotherapy in terms of PFS and ORR, with no significant difference in OS. Non-hematological adverse effects such as hand-foot syndrome were fewer with a combination regimen. However, hematological adverse events were fewer with capecitabine monotherapy regimen.

25 August 2020 in Annals of Clinical Oncology
Verified
Journal Article
Open access
PDF file
LALouai Alsaloumi
Louai Alsaloumi
SSShaima Shawagfeh
Shaima Shawagfeh
BBBilgen Başgut
Bilgen Başgut
Having cancer impacts the patient both psychologically and physically. However, if cancer is accompanied with HFS, the patient’s condition gets even worse. Capecitabine is a prodrug approved to treat several types of cancer such as breast and colorectal cancer. It is associated with several adverse effects such as hand and foot syndrome (HFS) which mostly affects the palms and legs. The provoked mechanisms of HFS are not clear yet. They require further validation of HFS pathogenesis. Up to now, prevention and treatment of HFS are not clearly solidified. Evidence supports the use of celecoxib, urea-based creams, and vitamin E to reduce the severity and the incidence of HFS. This review aims to provide the gaps and ways to further clinical evaluations.

11 July 2025 in Medicine
Verified
Journal Article
Open access
ETEsra Taybeh
Esra Taybeh
Abdallah Y. NaserAbdallah Y. Naser
Abdallah Y. Naser
ATAdnan Taybeh
Adnan Taybeh
ZAZahra K. Alsairafi
Zahra K. Alsairafi
HAHassan Alwafi
Hassan Alwafi
MBMohamed Bahlol
Mohamed Bahlol
Low health literacy is associated with poor health outcomes, inefficient use of healthcare resources, higher mortality risk, and increased costs. The aim of this research is to explore public awareness and preparedness regarding various treatment options for acute medical events and to assess the competence in assessing the urgency of such medical situations in 6 Middle Eastern countries namely, Jordan, Saudi Arabia, Egypt, Lebanon, Kuwait, and Bahrain. This research involved a cross-sectional survey study design to assess public knowledge and preparedness about emergency medicine using an online questionnaire distributed through accessible online channels between March 1, 2024 until September 11, 2024. A total of 4909 participants were involved in this research. The questionnaire was developed based on a thorough review of existing literature related to public knowledge and public preparedness of emergency medicine. Binary logistic regression analysis was used to identify significant predictors of insufficient and problematic emergency health literacy (EHL) levels. Overall, the most commonly known emergency care service was identifying emergency practice nearby (81.4%). The least commonly known emergency care service was identifying the rescue service (48.1%). The highest degree of difficulty reported by the study participants was the difficulties they face to evaluate when to use emergency medical services (39.6%). The mean public EHL score for the study sample was 2.77 (standard deviation [SD]: 0.44) out of 3. The mean public EHL score ranged between 2.69 (SD: 0.50) for Kuwait and 2.89 (SD: 0.56) for Bahrain. The majority of the study participants (75.1%) demonstrated problematic EHL. Males, young participants aged 24 to 30 years and elderly participants aged 61 years and older, highly educated individuals, high income level individuals, and those who work in the healthcare sector were less likely to have inadequate and problematic EHL levels (P < .05). The findings of the present study indicate limited emergency public EHL among 6 of the Middle Eastern countries, highlighting the need for interventions to promote public knowledge and capabilities. Educational campaigns that promote EHL should target females, those with low education and socioeconomic status, those in age range of 30 to 60 years, and those who do not work in health sector.

10 April 2026 in Current Research in Nutrition and Food Science Journal
Verified
Journal Article
Open access
ASAla’ Sirhan
Ala’ Sirhan
QJQais Jarrar
Qais Jarrar
RARami Ayoub
Rami Ayoub
ZAZead Helmi Abudayeh
Zead Helmi Abudayeh
LALouai Alsaloumi
Louai Alsaloumi
LALukman Bola Abdulra'uf
Lukman Bola Abdulra'uf
The safety level and impacts of bioaccumulation of Cd, Hg and Pb various fish samples were determined in the present study. The accurate determination of the concentration of metals in fish samples is necessary due to the health risks associated with the bioaccumulation of heavy metals in the human system through the ingestion of contaminated fish samples. AAS analysis was employed after microwave-assisted wet acid digestion. The results showed that frozen tuna has the highest concentration of mercury (157.09 ± 23.04 µg/kg), that is in line with the pattern of heavy metal accumulation of in fishes. Non-predatory fish samples, including bata (0.87 ± 0.01 µg/kg) and chapil (0.06 ± 0.01 µg/kg), had lower mercury levels. In all samples, the amount of Pb was lower than the level of Hg. Merluccius pacifia had the highest concentration of Pb (27.08 ± 0.00 µg/kg), whereas salmon (1.33 ± 0.15 µg/kg) and and basa fillets (1.51 ± 0.72 µg/kg) had the lowest concentrations of Pg. Cadmium was found to absent in all the fish samples examined. The results of the present study showed that environmental exposure and proximity to industrial effluents have impacts on the bioaccumulation of heavy metals. It was also observed that removing organs that have the potential to bioaccumulate heavy metals is one way to prevent heavy metal contamination, through appropriate handling and preparation techniques. The concentration of Pb and Hg were found below the EU limit. Mercluccius pacifica had the highest THQ for Pb (1.4), whereas tuna had the highest THQ for Hg (84.82). THQ greater than 1 for Hg was surpassed by more than 10 species, suggesting a health risk.

Verified
Journal Article
Open access
PDF file
MOMeyrem Osum
Meyrem Osum
LALouai Alsaloumi
Louai Alsaloumi
Rasime KalkanRasime Kalkan
Rasime Kalkan
Background/Objectives: Gliomas are the most common tumours of the central nervous system (CNS), classified into grades I to IV based on their malignancy. Genetic and epigenetic alterations play a crucial role in glioma progression. DNA methyltransferases (DNMTs) are vital enzymes responsible for DNA methylation, with DNMT1 and DNMT3 catalysing the addition of a methyl group to the 5-carbon of cytosine in CpG dinucleotides. Targeting DNMTs with DNA methyltransferase inhibitors (DNMTi) has become a promising therapeutic approach in tumour treatment. In this study, in silico screening tools were employed to evaluate potential inhibitors of DNMT1, DNMT3A, and DNMT3B for the treatment of glioblastoma multiforme (GBM). Methods: The Gene2Drug platform was used to screen compounds and rank them based on their capacity to dysregulate DNMT genes. PRISM viability assays were performed on 68 cell lines, and DepMap data were analyzed to assess the antitumor activities of these compounds and their target genes. Candidate drug similarity was evaluated using DSEA, and compounds with p < 1 × 10−3 were considered statistically significant. Gene-compound interactions for DNMT1, DNMT3A, and DNMT3B were confirmed using Expression Public 24Q2, while Prism Repositioning Public data were analyzed via DepMap. Results: Glioblastoma cell lines showed sensitivity to compounds including droperidol, demeclocycline, benzthiazide, ozagrel, pizotifen, tracazolate, norcyclobenzaprine, monocrotaline, dydrogesterone, 6-benzylaminopurine, and nifedipine. SwissTargetPrediction was utilised to identify alternative molecular targets for selected compounds, revealing high-probability matches for droperidol, pizotifen, tracazolate, monocrotaline, dydrogesterone, and nifedipine. Conclusions: Integrating computational approaches with biological insights and conducting tissue-specific and experimental validations may significantly enhance the development of DNMT-targeted therapies for gliomas.